Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company.
Our shares are listed on the SIX Swiss Exchange (NWRN).
Our mission is to discover, develop and commercialise novel drugs to treat
diseases of the Central Nervous System (CNS) and pain.
January 11-14, 2016 - the Westin St. Francis, San Francisco, US
December 1–2, 2015, The New York Palace, New York, NY, US